[email protected] +357 96 030922 Contact Us | FAQ |
Advanced search

Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

Lexicon Pharmaceuticals Nine Months 2021 Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry

 US$ 750.00

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...

October 2021 -

Mallinckrodt Nine Months 2021 Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry

 US$ 750.00

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...

October 2021 -

Merck Nine Months 2021 Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Animal Health Industry

 US$ 750.00

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...

October 2021 -

Momenta Pharmaceuticals Nine Months 2021 Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry

 US$ 750.00

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...

October 2021 -

Mylan Nine Months 2021 Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry

 US$ 750.00

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...

October 2021 -

Novartis Nine Months 2021 Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry

 US$ 750.00

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...

October 2021 -

Novo Nordisk Nine Months 2021 Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry

 US$ 750.00

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...

October 2021 -

Perrigo Nine Months 2021 Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry

 US$ 750.00

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...

October 2021 -

Pfizer Nine Months 2021 Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry

 US$ 750.00

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...

October 2021 -

Phibro Nine Months 2021 Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Animal Health Industry

 US$ 750.00

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...

October 2021 -

Roche Nine Months 2021 Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry

 US$ 750.00

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...

October 2021 -

Sanofi Nine Months 2021 Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry

 US$ 750.00

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...

October 2021 -

Shire Nine Months 2021 Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry

 US$ 750.00

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...

October 2021 -

Teva Pharmaceuticals Nine Months 2021 Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry

 US$ 750.00

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...

October 2021 -

Tilray Nine Months 2021 Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry

 US$ 750.00

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...

October 2021 -

Valeant Pharmaceuticals Nine Months 2021 Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry

 US$ 750.00

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...

October 2021 -

Vertex Pharmaceuticals Nine Months 2021 Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry

 US$ 750.00

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...

October 2021 -

Virbac Nine Months 2021 Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Animal Health Industry

US$ 750.00

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...

October 2021 -

Zoetis Nine Months 2021 Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Animal Health Industry

 US$ 750.00

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...

October 2021 -

Zoetis Nine Months 2021 Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry

 US$ 750.00

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...

October 2021 -

Global Anti-Fungal Drugs Market, By Drug Class (Azoles, Echinocandins, Polyenes, Allylamines, Others), By Indication (Candidiasis, Aspergillosis, Mucormycosis, Dermatophytosis, Others), By Infection Type (Superficial Fungal Infection, Systemic Fungal Infection), By Route of Administration (Topical, Oral, Parenteral, Others), By End User (Homecare, Hospitals, Clinics, Others) By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy), By Region, Competition Forecast & Opportunities, 2026

 US$ 4,500.00

Global anti-fungal drugs market is expected to reach USD28484.69 million by 2026, growing at CAGR of 10.39% over the forecast period. Fungal infections can lead to diseases including fungal pneumonia,...

October 2021 114 pages

Acute Graft-versus-Host Disease - Pipeline Insight, 2021

 US$ 2,000.00

This report can be delivered to the clients within 48 hours DelveInsight’s, “Acute Graft-versus-Host Disease - Pipeline Insight, 2021,” report provides comprehensive insights about 20+ companies and...

October 2021 60 pages

Chikungunya virus infections - Pipeline Insight, 2021

 US$ 1,500.00

This report can be delivered to the clients within 48 hours DelveInsight’s, “Chikungunya virus infections - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10...

October 2021 60 pages

Medical Marijuana - Cannabidiol – Pipeline Insight, 2021

 US$ 2,500.00

This report can be delivered to the clients within 3-4 Business Days DelveInsight’s, “Medical Marijuana - Cannabidiol – Pipeline Insight, 2021,” report provides comprehensive insights about 25+ comp...

October 2021 60 pages

Mucosa-associated Lymphoid Tissue (MALT) Lymphoma - Pipeline Insight, 2021

 US$ 1,500.00

This report can be delivered to the clients within 48 hours DelveInsight’s, “Mucosa-associated Lymphoid Tissue (MALT) Lymphoma – Pipeline Insight, 2021,” report provides comprehensive insights about...

October 2021 60 pages

Natural Killer Cell Therapies - Pipeline Insight, 2021

 US$ 3,000.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight’s, “Natural Killer Cell Therapies - Pipeline Insight, 2021,” report provides comprehensive insights about 100+ comp...

October 2021 300 pages

Stomatitis - Pipeline Insight, 2021

 US$ 1,500.00

This report can be delivered to the clients within 48-72 hours DelveInsight’s, “Stomatitis – Pipeline Insight, 2021,” report provides comprehensive insights about 15+ companies and 15+ pipeline drug...

October 2021 60 pages

T-Cell Acute Lymphoblastic Leukemia - Pipeline Insight, 2021

 US$ 1,500.00

This report can be delivered to the clients within 48-72 hours DelveInsight’s, “T-Cell Acute Lymphoblastic Leukemia – Pipeline Insight, 2021,” report provides comprehensive insights about 12+ compan...

October 2021 60 pages

TCR therapy - Pipeline Insight, 2021

 US$ 2,000.00

This report can be delivered to the clients within 3-5 business days DelveInsight’s, “TCR therapy – Pipeline Insight, 2021,” report provides comprehensive insights about 25+ companies and 35+ pipeli...

October 2021 60 pages

Zika Virus Infection - Pipeline Insight, 2021

 US$ 1,500.00

This report can be delivered to the clients within 48 hours DelveInsight’s, “Zika Virus Infection - Pipeline Insight, 2021,” report provides comprehensive insights about 12+ companies and 12+ pipeli...

October 2021 60 pages

Anti CD47 Drugs Market by Target Disease Indication (Acute Myeloid Leukemias, Non-Hodgkin Lymphoma, Colorectal Cancers, Diffuse Large B-cell Lymphoma, Myelodysplastic Syndromes, Non-Small Cell Lung Cancers, Ovarian Epithelial Cancer, Oral Muscositis, Small Cell Lung Cancers), Type of Molecule (Biologics and Small Molecule) Key Players and Key Geographical Regions (US, France, Germany, Italy, Spain, UK, Australia, China, India and Israel): Industry Trends and Global Forecasts, 2021-2035

 US$ 4,799.00

The anti CD47 market is expected to reach USD 0.1 billion in 2023 and anticipated to grow at a CAGR of 42.9% during the forecast period 2021-2035. According to the World Health Organization (WHO), can...

October 2021 178 pages

Global PDGFR Inhibitors Market, Drug Sales & Clinical Trials Insight 2026

 US$ 2,400.00

Please note: extra shipping charges are applied when purchasing Hard Copy License depending on the location. Global PDGFR Inhibitors Market, Drug Sales & Clinical Trials Insight 2026 Report Analysis...

October 2021 150 pages

Global MEK Inhibitors Market, Drug Sales & Clinical Trials insight 2026

 US$ 2,400.00

Please note: extra shipping charges are applied when purchasing Hard Copy License depending on the location. Global MEK Inhibitors Market, Drug Sales & Clinical Trials insight 2026 Report Analysis &...

October 2021 172 pages

Global TRK Inhibitors Market, Drug Sales & Clinical Trials insight 2026

 US$ 2,400.00

Please note: extra shipping charges are applied when purchasing Hard Copy License depending on the location. Global TRK Inhibitors Market, Drug Sales & Clinical Trials Insight 2026 Report Analysis &...

October 2021 180 pages

20s Proteasome - Drugs in Development, 2021

 US$ 3,500.00

20s Proteasome - Drugs in Development, 2021 SUMMARY 20s Proteasome pipeline Target constitutes close to 9 molecules. Out of which approximately 6 molecules are developed by companies and remaining by...

September 2021 76 pages

Adrenoleukodystrophy (Adrenomyeloneuropathy/ Schilder-Addison Complex) - Drugs in Development, 2021

 US$ 2,000.00

Adrenoleukodystrophy (Adrenomyeloneuropathy/Schilder-Addison Complex) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Adrenoleu...

September 2021 110 pages

Amyotrophic Lateral Sclerosis (Central Nervous System) - Drugs in Development, 2021

 US$ 2,500.00

Amyotrophic Lateral Sclerosis (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Amyotrophic Lateral Scle...

September 2021 945 pages

Anaphylaxis (Immunology) - Drugs in Development, 2021

 US$ 2,000.00

Anaphylaxis (Immunology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Anaphylaxis - Drugs In Development, 2021, provides an...

September 2021 67 pages

Aplastic Anemia (Hematology) - Drugs in Development, 2021

 US$ 2,000.00

Aplastic Anemia (Hematology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Aplastic Anemia - Drugs In Development, 2021, prov...

September 2021 138 pages

Aspergillosis (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Aspergillosis (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Aspergillosis - Drugs In Development, 2021,...

September 2021 206 pages

Burkholderia pseudomallei Infections (Melioidosis) (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Burkholderia pseudomallei Infections (Melioidosis) (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Burkhol...

September 2021 54 pages

C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Drugs in Development, 2021

 US$ 3,500.00

C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Drugs in Development, 2021 SUMMARY C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or C...

September 2021 126 pages

C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) - Drugs in Development, 2021

 US$ 3,500.00

C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) - Drugs in Development, 2021 SUMMARY According to the recently published report 'C5a Anaphylatoxin Chemotactic Receptor 1 - Drugs In Developmen...

September 2021 79 pages

Cancer Pain (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Cancer Pain (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cancer Pain - Drugs In Development, 2021,...

September 2021 169 pages

Catenin Beta 1 (Beta Catenin or CTNNB1) - Drugs in Development, 2021

 US$ 3,500.00

Catenin Beta 1 (Beta Catenin or CTNNB1) - Drugs in Development, 2021 SUMMARY Catenin Beta 1 (Beta Catenin or CTNNB1) - Catenin beta-1 or ?-catenin is a protein that is encoded by the CTNNB1 gene. In t...

September 2021 74 pages

Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) - Drugs in Development, 2021

 US$ 3,500.00

Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) - Drugs in Development, 2021 SUMMARY According to the recently published report 'Complement C5 - Drugs In Develo...

September 2021 202 pages

Cryptosporidiosis (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Cryptosporidiosis (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cryptosporidiosis - Drugs In Development...

September 2021 36 pages

Cytomegalovirus (HHV-5) Infections (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Cytomegalovirus (HHV-5) Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cytomegalovirus Infecti...

September 2021 200 pages

Diphtheria (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Diphtheria (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diphtheria - Drugs In Development, 2021, provid...

September 2021 93 pages

End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) (Genitourinary Disorders) - Drugs in Development, 2021

 US$ 2,000.00

End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) (Genitourinary Disorders) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline...

September 2021 44 pages

Filters

Clear all

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1